120 related articles for article (PubMed ID: 12615415)
1. Preparation and purification of cationic solid lipid nanospheres--effects on particle size, physical stability and cell toxicity.
Heydenreich AV; Westmeier R; Pedersen N; Poulsen HS; Kristensen HG
Int J Pharm; 2003 Mar; 254(1):83-7. PubMed ID: 12615415
[TBL] [Abstract][Full Text] [Related]
2. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
[TBL] [Abstract][Full Text] [Related]
3. The effect of a lipid composition and a surfactant on the characteristics of the solid lipid microspheres and nanospheres (SLM and SLN).
Sznitowska M; Wolska E; Baranska H; Cal K; Pietkiewicz J
Eur J Pharm Biopharm; 2017 Jan; 110():24-30. PubMed ID: 27815177
[TBL] [Abstract][Full Text] [Related]
4. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.
Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A
Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
6. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
7. Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants.
Keck CM; Kovačević A; Müller RH; Savić S; Vuleta G; Milić J
Int J Pharm; 2014 Oct; 474(1-2):33-41. PubMed ID: 25108048
[TBL] [Abstract][Full Text] [Related]
8. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
10. The effect of formulative parameters on the size and physical stability of SLN based on "green" components.
Soddu E; Rassu G; Cossu M; Giunchedi P; Cerri G; Gavini E
Pharm Dev Technol; 2016; 21(1):98-107. PubMed ID: 25331189
[TBL] [Abstract][Full Text] [Related]
11. Impact of surfactant properties on oxidative stability of beta-carotene encapsulated within solid lipid nanoparticles.
Helgason T; Awad TS; Kristbergsson K; Decker EA; McClements DJ; Weiss J
J Agric Food Chem; 2009 Sep; 57(17):8033-40. PubMed ID: 19691283
[TBL] [Abstract][Full Text] [Related]
12. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
13. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
[TBL] [Abstract][Full Text] [Related]
14. Optimization of linalool-loaded solid lipid nanoparticles using experimental factorial design and long-term stability studies with a new centrifugal sedimentation method.
Pereira I; Zielińska A; Ferreira NR; Silva AM; Souto EB
Int J Pharm; 2018 Oct; 549(1-2):261-270. PubMed ID: 30075252
[TBL] [Abstract][Full Text] [Related]
15. Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
Wolska E; Sznitowska M
Int J Pharm; 2013 Jan; 441(1-2):449-57. PubMed ID: 23164704
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles and nanoemulsions with solid shell: Physical and thermal stability.
Koroleva M; Portnaya I; Mischenko E; Abutbul-Ionita I; Kolik-Shmuel L; Danino D
J Colloid Interface Sci; 2022 Mar; 610():61-69. PubMed ID: 34922082
[TBL] [Abstract][Full Text] [Related]
17. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
Zimmermann E; Müller RH
Eur J Pharm Biopharm; 2001 Sep; 52(2):203-10. PubMed ID: 11522487
[TBL] [Abstract][Full Text] [Related]
18. Influence of surfactant and lipid type on the physicochemical properties and biocompatibility of solid lipid nanoparticles.
Pizzol CD; Filippin-Monteiro FB; Restrepo JA; Pittella F; Silva AH; Alves de Souza P; Machado de Campos A; Creczynski-Pasa TB
Int J Environ Res Public Health; 2014 Aug; 11(8):8581-96. PubMed ID: 25141003
[TBL] [Abstract][Full Text] [Related]
19. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
